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Abstract
The effective control of vaccine-preventable diseases general-
ly requires indefinite maintenance of extremely high rates of time-
ly vaccination. Therefore, vaccine hesitancy is of paramount
importance and needs to be addressed. In Italy, regulations about
vaccinations are controversial and, to some extent, inconsistent.
Even though the childhood vaccinations are mandatory by law
(Italian Law n. 891/1939, n. 292/1963, n.51/1966 and n.
165/1991), the limited deterrent effectiveness of the sanctioning
system, and the changes introduced by the Italian Constitutional
Law n. 3/2001 (devolution of almost all the competences and
responsibilities in health matters to the Regions and the
Autonomous Provinces), were the fertile ground in which new
vaccine policies were generated and developed, radically different
from the existing ones: many Regions, based on what was decided
in 2005 - on an experimental basis - by the State-Regions
Conference, decided to abolish the vaccination obligation and/or
to stop the imposition of administrative sanctions on non-compli-
ant parents. In addition, since then, there is a worrying tendency to
decline vaccinations due to the parents’ mistrust in pharmaceutical
companies and health policies. Therefore, recently, the Italian
government decided to deploy an emergency ordinance (Italian
Decree Law n. 73/2017). In this article, the authors are going to
illustrate the current situation in Italy concerning vaccination pol-
icy, from a legislative and social point of view. 
Vaccination policy
Immunization is widely considered to be one of the greatest
achievements of public health policies. 
Yet, in Italy, concerns about vaccine safety have led a
worrying number of families to decline the recommended vacci-
nation plans for their children. This alarming tendency is, curren-
tly, leading to a resurgence of some diseases and, in addition, to
the actual risk of outbreaks. As already pointed out by some
American authors, vaccine refusal has been associated with out-
breaks of invasive Haemophilus influenzae type b disease, varicel-
la, pneumococcal disease, measles, and pertussis, resulting in the
unnecessary suffering of young children and waste of limited
public health resources.1
Most of those concerns are based on the fear of life-threate-
ning side effects. Indeed, it is well known that vaccines can actual-
ly cause some adverse effects, even serious ones, but they are
extremely rare, especially if compared to the benefits that vaccines
provide (Table 1). 
In 1998, Wakefield et al. published an article in which a pos-
sible relationship between measles/mumps/rubella vaccine and
autism was hypothesized.2 Many studies since then showed no
causal relation between measles/mumps/rubella vaccine and auti-
sm.3-6 Yet, the controversy lead to a diffuse confusion, especially
among children’s parents, about this issue. Then, in 2004, ten of
the authors of the Lancet study formally retracted their support for
the published hypothesis. Finally, the Lancet withdrew the article
in 2010.7 Moreover, in literature there is strong scientific evidence
that childhood vaccines are not associated with autism or leuke-
mia: for instance, a systematic literature, published by Maglione et
al. in 2014, examined 67 studies, finding that measles/mumps/
rubella vaccine is not associated with autism (Table 1).8,9
In fact, in most well-developed countries, the high rate of
childhood vaccination coverage indicates that immunization pro-
grams remain a generally accepted and diffuse public health mea-
sure. It is interesting to notice that Italy is one of the few countries
in which vaccines are mandatory by law. This fact appears to be in
contrast with the ongoing tendency not to vaccinate children,
endorsed mostly by misinformation provided by social media and
blogs.
Nonetheless, as often happens in Italy, the regulations about
this delicate topic are controversial and, to some extent, inconsi-
stent. The recent Italian Decree Law n. 73/2017, that we are going
to illustrate below, is only the “icing on the cake”, a very complex
cake, made of many layers. In the following pages, we are going
to provide an overview of a situation that other authors have
already defined, very pertinently, as an oxymoron.10 In fact, vac-
cines in Italy are compulsory by law since the 30s (diphtheria),
and the 60s (anti-tetanus, anti-poliomyelitis). Notwithstanding,
regional laws generated a growing inhomogeneity, starting from
Significance for public health
Immunization is widely considered to be one of the greatest achievements of
public health policies. The effective control of vaccine-preventable diseases
generally requires indefinite maintenance of extremely high rates of timely
vaccination. However, vaccines represent one of the most important aspects
of pediatric preventive care, as they represent an essential tool to prevent ill-
ness and save lives. Yet, the success of this fundamental public health meas-
ure is directly dependent on parental compliance, which must be increased
using evidence-based communication strategies to address vaccine hesitan-
cy. Therefore, vaccine hesitancy is an extremely important issue that needs
to be urgently addressed. In Italy, concerns about vaccine safety have led a
worrying number of families to decline the recommended vaccination plans
for their children. This alarming tendency is, currently, leading to a resur-
gence of some diseases and, in addition, to the actual risk of outbreaks.
Regional laws generated a growing inhomogeneity, starting from 2005, caus-
ing an alarming drop of  immunization  rate, being currently 85%, one of the
lowest in Europe. 
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Veneto in 2008, causing an alarming drop of  immunization  rate,
being currently 85%, one of the lowest in Europe.10 Note that a
93-95% coverage is required to grant herd immunity.
As stated by art. 32 of the Italian Constitution: The Republic
safeguards health as a fundamental right of the individual and as
a collective interest, and guarantees free medical care to the indi-
gent. No one may be obliged to undergo any given health treatment
except under the provisions of the law. The law cannot under any
circumstances violate the limits imposed by respect for the human
person. It is important to note that health (both individual and col-
lective) is not the only right safeguarded by this article. The Italian
Supreme Court repeatedly stated that the right to health must be
distinguished from the right to self-determination, the latter being
a form of respect for personal freedom and a mean to pursue an
individual’s best interestsi and originating from both art. 32 and art.
13 of the Italian Constitution: Personal liberty is inviolable. No
form of detention, inspection or personal search nor any other
restriction on personal freedom is admitted, except by a reasoned
warrant issued by a judicial authority, and only in the cases and
the manner provided for by law. In exceptional cases of necessity
and urgency, strictly defined by the law, law-enforcement authori-
ties may adopt temporary measures that must be communicated to
the judicial authorities within forty-eight hours. Should such mea-
sures not be confirmed by the judicial authorities within the next
forty-eight hours, they are revoked and become null and void. All
acts of physical or moral violence against individuals subject in
any way to limitations of freedom shall be punished. The law esta-
blishes the maximum period of preventive detention.11
As stated by the Italian Constitutional Court, informed consent
must be considered as a fundamental principle when dealing with
health protection, and its translation into reality is determined by
State laws.ii
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Table 1. Comparison between disease-related risks and vaccine-related risks.
Disease                           Disease-related risks                                                                Vaccine-related risks
Measles                                     Pneumonia: 1/20; Encephalitis: 1/2000; Death: 1/3,000                                 Encephalitis or severe allergic reactions: 1/1,000,000
Mumps                                       Encephalitis: 1/300                                                                                               
Rubella                                       Congenital rubella: 1/4 if contracted at the beginning of pregnancy       
Diphtheria                                 Death: 1/20                                                                                                             Inconsolable crying followed by complete recovery: 1/100;
Tetanus                                      Death: 3/100                                                                                                           Convulsions or shock followed by complete recovery: 1/1750;
Pertussis                                   Pneumonia: 1/8; Encephalitis: 1/20; Death: 1/20                                            Acute encephalopathy: 0-10.5/1,000,000; Death: unproven
Varicella                                     Incidence: 4000/100,000; Lethality: 4-9/100,000;                                            Varicella-like rash: 3.8%; Pneumonia: <1%; Febrile
                                                    Hospitalization: 1,3-4,5/100,000;  Neurological complications:                  convulsions: <0.1%; Severe allergic reactions: <0.01%
                                                    0.4-10.1% of hospitalized patients; Pneumonia: 5-14%; 
                                                    Skin superinfections: 36% of hospitalized patients                                     
Meningococcal meningitis    Lethality: 10%; Complications: 25% (amputations,                                      Dizziness: <1/100; Paresthesia, anaphylactic reactions: 
                                                    skin lesions, hemiplegia, mental retard, epilepsy,                                      <1/10,000
                                                    neurological deafness, post-traumatic stress disorder, 
                                                    depression, anxiety)                                                                                           
Invasive pneumococcal         Lethality: 15-20% in case of pneumococcal sepsis in adults,                    Hypersensitivity reactions including facial edema, 
disease (IPD)                           30-40% in case of pneumococcal sepsis in people over 65,                     dyspnea, bronchospasm, convulsions 
                                                    12% in case of pneumococcal meningitis 12%.                                            (including febrile convulsions), rash, urticaria or
                                                    Neurological sequelae: 40% of pneumococcal                                            urticaria rash, anaphylactic reactions, angioedema, 
                                                    meningitis survivors                                                                                            hyporesponsive-hypotonic episodes, urticaria on 
Non-invasive                             CAP mortality: 5-15% in hospitalized patients,                                             the site of injection, itching on the site of injection, 
pneumococcal disease          20-45% in ICU patients, 40% in people over 80                                             hot flushes, apnea in very premature newborns: 
                                                                                                                                                                                     <1/1,000. Lymphadenopathy (near the site of
                                                                                                                                                                                     injection), erythema multiforme: <1 /10,000
Haemophilus Influenzae       Lethality: 3-6%. Complications: 20% of patients who                                  Allergic reactions, angioedema, hypotonic-hyporesponsive
infection (HiB)                        survive the Hib meningitis report hearing loss and other                       episodes, convulsions, syncope or vasovagal reactions
                                                    neurological sequelae.                                                                                       during injection, drowsiness, apnea, urticaria, rash, 
                                                                                                                                                                                     extensive swelling of the injected limb, hardening 
                                                                                                                                                                                     of the site of injection
Poliomyelitis                             Fever, weakness, headache, nausea, flu-like syndrome,                           Local reactions on the injection site (pain, redness,
                                                    nuchal/spinal rigidity, pain in the limbs: 4-8%.                                             hardening, edema): ≥ 1/10
                                                    Permanent paralysis: 1%. Mortality: 5-15% of cases 
                                                    of acute paralytic poliomyelitis                                                                        
Hepatitis B                                Mortality due to acute hepatitis: 2%                                                               Lymphadenopathy, arthralgia, paresthesia, hives, itching and 
                                                    Development of a chronic infection:                                                              rash: <1/1000.
                                                    > 30% in children, <5% in adults                                                                     Thrombocytopenia, encephalitis, encephalopathy, 
                                                    Complications of chronic infections:                                                             convulsions, paralysis, neuritis, neuropathy, hypoaesthesia, 
                                                    liver cirrhosis 25%, liver cancer 5%                                                                 apnea in very premature newborns very premature, 
                                                                                                                                                                                     erythema multiforme, angioneurotic oedema, lichen planus,
                                                                                                                                                                                     arthritis, muscle weakness, meningitis, vasculitis,
                                                                                                                                                                                     hypotension, anaphylaxis, allergic reactions including
                                                                                                                                                                                     anaphylactoid reactions and serum sickness–like reaction.
iItalian Supreme Court (3rd civil division), sentence n. 2847/2010
iiItalian Constitutional Court, sentence n. 438/2008
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Lawmakers have always been trying to balance out the indivi-
dual’s rights to health and self-determination and the  right of the
collectivity to health by allowing a limited number of compulsory
health treatments and medical examinations. The most popular
form of compulsory treatment is the forced psychiatric hold, origi-
nally regulated by the so-called “Basaglia Act” (Italian law n.
180/1978), which was soon transposed into the “Italian National
Health Service Institution Act” (Italian law n. 833/1978).
Mandatory vaccinations are another form of unintentional
treatments, often performed on children. Based on Italian law, peo-
ple gain their contractual and mental capacity when turning eigh-
teen years old (as stated by art. 2 of the Italian Civil Code and arts.
85, 97 and 98 of the Italian Penal Code). Therefore, only adults can
fully defend their rights to health and self-determination, and pro-
cedures on minors must usually be endorsed by his/her parents or
legal guardian(s).
However, when dealing with a minor’s health, it is essential to
keep in mind that he/she must be “protected from parents not ful-
filling their duty of care”,iii as required by arts. 30 and 31 of the
Italian Constitution.
Indeed, “in the case of a minor, we are not dealing with his/her
self-determination, but with his/her parents’ authority and duty to
act to avoid damages or actual dangers to his/her health, and we
cannot grant parents a full freedom to make potentially harmful
decisions”.iv
In a period of worrying tendency to decline vaccinations due to
the parents’ skepticism about pharmaceutical companies and
health policies, the Italian government has justifiably decided to
deploy an emergency ordinance.
However, we would like to remind that, even before the Italian
Decree Law n. 73/2017 was approved, mandatory vaccinations for
children included all of the following: anti-diphtheria (Italian Law
n. 891/1939), anti-tetanus (Italian Law n. 292/1963), anti-
poliomyelitic (Italian Law n.51/1966) and anti-hepatitic B (Italian
Law n. 165/1991). In the event of non-compliance, administrative
sanctions (ranging from 10 to 258 euros) were imposed (there was
no specific sanction for the omission of the diphtheria vaccination,
which was however generally administered in association with the
anti-tetanus vaccination).
The above-mentioned regulations, and their subsequent
amendments and additions, provided that the vaccination certifica-
tes had to be presented to primary schools to complete enrollment.
Furthermore, for about thirty years (from the late 1960s to the late
1990s), “school directors and heads of public or private educatio-
nal institutions” could not admit to school or exams the ones who
did not prove, “with the presentation of a certificate issued under
the law, to have been subjected to mandatory vaccinations and
revaccinations”.v Following the approval of the Presidential
Decree n. 355/1999, this provision was renewed as follows: “In the
case of non-submission of the certification or declaration ..., the
school director or the head of the institution communicates the fact
within five days, for the opportune and timely interventions, to the
unit company local health of the pupil and the Ministry of Health.
Failure to certify does not imply the refusal of the pupil’s admis-
sion to compulsory schooling or exams”. Health authorities
(mayors, Regions or State) still maintained the right to take urgent
action in the event of health emergencies or public hygiene, based
on art. 117 of the Italian Legislative Decree n. 112/1998.
The limited deterrent effectiveness of the already mentioned
sanctioning system, and the changes introduced by the Italian
Constitutional Law n. 3/2001 (devolution of almost all the compe-
tences and responsibilities in health matters to the Regions and the
Autonomous Provinces), were the fertile ground in which new vac-
cine policies were generated and developed, radically different
from the existing ones: many Regions, based on what was decided
in 2005 - on an experimental basis - by the State-Regions
Conference, decided to abolish the vaccination obligation and/or to
stop the imposition of administrative sanctions on non-compliant
parents.
At the same time, however, there was a tendency to offer acti-
vely and freely, especially for the newborns’ cohorts, some further
vaccinations, called “recommended” and included in the vaccina-
tion timetables (see Italian National Health Plan 1996-1998, Italian
National Plan for Vaccines 1999-2000, New Italian National Plan
for Vaccines 2005-2007, Italian National Plans for Vaccine
Prevention 2012-2014 and 2017-2019): measles, mumps, rubella,
pertussis, Haemophilus influenzae type b, meningococcus B and
C, pneumococcus, varicella, HPV, rotavirus. It should also be
noted that vaccinations have been included in the LEA (“Livelli
Essenziali di Assistenza”, fundamental assistance standards) since
2002 (see Decree of the President of the Council of Ministers 29th
November 2001).
Meanwhile, jurisprudence had also dealt with the subject of the
indemnity of the (rare, but possible) damages consequent to man-
datory health treatments. Following the Italian Constitutional
Court’s pronunciation n. 307/1990 (which had declared “the con-
stitutional illegitimacy of the law of February 4, 1966, No. 51
(Obligation of the anti-poliomyelitic vaccination) in the part in
which it does not provide, by the State, a fair indemnity for the case
of damage deriving ... from infection or other appreciable disease
causally due to the compulsory anti-poliomyelitic vaccination,
reported by the vaccinated child or other subject due to direct per-
sonal assistance given to the first”), Italian Law n. 210/1992 was
approved. It is still in force, and imposes a “Compensation in favor
of those injured by irreversible complications due to mandatory
vaccinations, transfusions and administration of blood products”.
Subsequent legislative measures (see Italian Law n. 641/1996) and
sentences of the Italian Constitutional Court (see judgments n.
118/1996, 27/1998, 423/2000 and 107/2012) have since then
expanded both the amount of the economic benefits, and the num-
ber of beneficiaries, providing for the indemnity payment to people
who had suffered a permanent impairment of the psycho-physical
integrity following the administration of only “recommended”
vaccines.12 Italian Law n. 229/2005, containing “Provisions on
compensation in favor of persons damaged by irreversible compli-
cations due to compulsory vaccinations”, established the provision
of further compensation to the injured parties (and/or their relati-
ves), in the form of a monthly check.
This complex regulatory framework generated great confusion
and a diffuse mistrust: vaccinations were no longer compulsory; in
some cases, they seemed to have been even harmful; at the same
time, more than ten vaccinations were offered free of charge. Many
people started to promote doubts about the usefulness and the real
safety of vaccinations; some raised (and still raise) perplexities
about the justification of the healthcare costs related to the purcha-
se and administration of vaccines. On the other hand, as highligh-
ted by the Italian Ministry of Health, “The vaccination coverage at
24 months from the year 2000, after an upward trend, stabilized in
the middle of the next decade ... The vaccine coverage for measles
and rubella, going from 90.4% (2013) to 85.3% (2015), is particu-
                                Article
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larly worrying and is cracking the international credibility of our
country”.vi
Even the Italian National Bioethics Committee (see the motion
“The importance of vaccinations”, approved on 24th April 2015)
and the Italian National Federation of the Medical Councils (see
the “Document on vaccines” by FNOMCeO, approved on 8th July
2016) had expressed concern in this regard.
Not without media controversy, region Emilia Romagna was
the first Italian Region to establish that the fulfillment of the vac-
cination obligation was a necessary requirement for admission to
kindergartens (see Regional Law n. 19/2016). A few months later,
similar rules were also approved in other regions. On 7th June
2017, after weeks of discussions, polemics and a tough tug of war
with the Minister of Education, the well-known Italian Decree Law
n. 73, containing “Urgent provisions concerning vaccination pre-
vention” was approved: the total amount of compulsory vaccina-
tions was brought to twelve; immunization following a natural
disease involved the exoneration from the vaccination obligation;
moreover, in the event of an established health hazard, in relation
to specific documented clinical conditions, vaccinations could be
completely omitted or delayed; the imposition of sanctions against
non-compliant parents (or guardians) and the prohibition of enrol-
ling unvaccinated minors to nursery schools and kindergartens
were restored; finally, it was envisaged that local health authorities
would report the non-fulfillment of the vaccination obligation to
the Public Prosecutor’s Office at the Juvenile Court.
The text of the law, as peremptory as poor in pragmatism, was
profoundly innovated by the conversion law n. 119/2017, still in
force:
• at present, mandatory vaccinations (including unaccompanied
foreign minors) are ten (anti-poliomyelitic, anti-diphtheria,
anti-tetanic, anti-pertussis, anti-hepatitis B, anti-Haemophilus
influenzae type b, anti-measles, anti-mumps, anti-rubella and
anti-varicella), according to the specific indications of the
national vaccination timetable for each birth cohort;
• “in case of established health hazard, in relation to specific
documented clinical conditions, attested by the general practi-
tioner or the pediatrician of free choice”, the administration
can be omitted or deferred; these students “are usually inclu-
ded in classes in which only vaccinated or immunized minors
are present”; school managers must inform the local health
authority of the classes in which more than two unvaccinated
minors are present;
• “The immunization following a natural disease, proven by the
notification made by the attending physician, according to
article 1 of the Health Ministry’s decree 15th December 1990
[notification, by the doctor, of all cases of diffuse diseases dan-
gerous for public health], or from the results of serological
analysis, exonerates from the obligation of the relative vacci-
nation”;
• the subject already immunized against a single pathology ful-
fills the vaccination obligation “as a rule and in any case
within the limits of the National Health Service, with vaccines
in single or combined formulation in which there is no antigen
for the infectious disease for which there is immunization”;
• three years after the entry into force of the law and then every
three years, the Minister of Health, on the basis of “verification
of epidemiological data, any adverse reactions reported in
implementation of the current provisions of law and vaccina-
tion coverage reached as well as eventual reported adverse
events”, may suspend the obligation to vaccinate minors again-
st measles, mumps, rubella and varicella;
• the vaccinations against meningococcus B and C, pneumococ-
cus and rotavirus are offered actively and free of charge for
children between the ages of zero and sixteen, but are not com-
pulsory;
• in the event of failure to comply with the vaccination obliga-
tion, parents, guardians or recipients are first of all “summoned
by the local health authority for an interview in order to provi-
de further information on vaccinations and to request that they
be carried out”;
• the persistent failure to comply with the legal obligation deter-
mines the imposition of an administrative fine of an amount
varying from 100 to 500 euros, unless the parents, guardians or
trustees provide, “within the period indicated in the act of con-
testation, to have administered to the minor the vaccine or the
first dose of the vaccination cycle, provided that the comple-
tion of the cycle foreseen for each compulsory vaccination
takes place in compliance with the timing established by the
vaccination schedule in relation to age”;
• there is no provision for the reporting of non-compliant
parents/guardians to the Public Prosecutor’s Office;
• failure to comply with vaccination obligations prevents access
to educational services for children and pre-schools, but not to
other levels of education, nor to regional vocational training
centers.
As recently mentioned by the Constitutional Courtvii, the
Italian Law Decree n. 73/2017 is, therefore, the inevitable conse-
quence of a context that is considerably different from that in force
until the early nineties: the changed socio-cultural structure requi-
red a rapid and peremptory legislative intervention. “Undoubtedly,
the legal bond became more stringent: what was previously recom-
mended, today has become mandatory”, but in the medical field
“recommending and prescribing are actions perceived as equally
necessary in view of a specific objective”. There are two elements,
introduced by the conversion law n. 119/2017, which were particu-
larly appreciated by the Italian Constitutional Court: on one hand,
the establishment of a preliminary interview with non-compliant
parents/guardians/carers, “an instrument particularly favorable to
mutual understanding, persuasion and conscious adherence”; on
the other hand, the provision of a future revision of the vaccination
obligations, which allows a “valorisation of the evolutionary dyna-
mics typical of medical-scientific knowledge”, on which the choi-
ces of health policy should always be based.
In conclusion, vaccine hesitancy is an extremely important
issue that needs to be addressed because the effective control of
vaccine-preventable diseases generally requires indefinite mainte-
nance of extremely high rates of timely vaccination.
Therefore, especially given the growing hesitancy to vaccinate
children, a broad range of measures are required, on many levels:
individual’s, health system managers’, physicians’. These measu-
res do not only include new (and better) laws, but also individually
tailored messages to parents who have vaccine concerns, especial-
ly first-time pregnant women. However, vaccines represent one of
the most important aspects of pediatric preventive care, as they
represent an essential tool to prevent illness and save lives. Yet, the
success of this fundamental public health measure is directly
dependent on parental compliance, which must be increased using
evidence-based communication strategies to address vaccine hesi-
tancy.
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vi Italian National Plan for Vaccine Prevention 2017-2019, page 25
vii Italian Constitutional Court, sentence n. 5/2018
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